Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients

Journal of the American Society of Hypertension

Volumn 7, Issue 1, 2013, Pages 46-60

  Panjabi, Sumeet ^a   Lacey, Michael ^b   Bancroft, Timothy ^b   Cao, Felix ^b  

^a DAIICHI SANKYO INC   (United States)

^b OPTUM   (United States)

Author keywords

Adherence; adrenergic receptor blockers; angiotensin antagonist; beta blockers; calcium channel blockers; cost benefit analysis; diuretics; drug therapy

Indexed keywords

ACEBUTOLOL; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BEPRIDIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARTEOLOL; CARVEDILOL; CLEVIDIPINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESMOLOL; FELODIPINE; HYDROCHLOROTHIAZIDE; LABETALOL; METOPROLOL; MIBEFRADIL; NADOLOL; NEBIVOLOL; PENBUTOLOL; PINDOLOL; PROPRANOLOL; SOTALOL; TIMOLOL; UNINDEXED DRUG; VERAPAMIL;

ARTICLE; CARDIOVASCULAR DISEASE; COMBINATION CHEMOTHERAPY; DRUG COST; HEALTH CARE UTILIZATION; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; COST-BENEFIT ANALYSIS; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 84872335137     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2012.11.001     Document Type: Article

References (33)

1. Vital signs: awareness and treatment of uncontrolled hypertension among adults - United States, 2003-2010 MMWR Morb Mortal Wkly Rep 2012 61
2. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, and T.M. Brown Heart Disease and Stroke Statistics-2011 Update: A report from the American Heart Association Circulation 123 2011 459 463
3. J.L. Priest, C.R. Cantrell, J. Fincham, C.L. Cook, and S.P. Burch Quality of care associated with common chronic diseases in a 9-state Medicaid population utilizing claims data: an evaluation of medication and health care use and costs Popul Health Manage 14 2011 1 12
4. P.A. Heidenreich, J.G. Trogdon, O.A. Khavjou, J. Butler, K. Dracup, and M.D. Ezekowitz Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association Circulation 123 2011 933 944
5. B.M. Egan, Y. Zhao, and R.N. Axon US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JAMA 303 2010 2043 2050
6. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
7. E.C. Yiannakopoulou, J.S. Papadopulos, D.V. Cokkinos, and T.D. Mountokalakis Adherence to antihypertensive treatment: a critical factor for blood pressure control Eur J Cardiovasc Prev Rehabil 12 2005 243 249
8. M. Veronesi, A.F. Cicero, M.G. Prandin, A. Dormi, E. Cosentino, and E. Strocchi A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice Vasc Health Risk Manage 3 2007 999 1005
9. P.M. Ho, D.J. Magid, S.M. Shetterly, K.L. Olson, P.N. Peterson, and F.A. Masoudi Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease Arch Intern Med 168 2008 271 276
10. B.L. van Wijk, O.H. Klungel, E.R. Heerdink, and A. de Boer Rate and determinants of 10-year persistence with antihypertensive drugs J Hypertens 23 2005 2101 2107
11. A.H. Gradman Rationale for triple-combination therapy for management of high blood pressure J Clin Hypertens (Greenwich) 12 2010 869 878
12. J.T. Wright Jr., J.K. Dunn, J.A. Cutler, B.R. Davis, W.C. Cushman, and C.E. Ford Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril JAMA 293 2005 1595 1608
13. R.H. Chapman, J.S. Benner, A.A. Petrilla, J.C. Tierce, S.R. Collins, and D.S. Battleman Predictors of adherence with antihypertensive and lipid-lowering therapy Arch Intern Med 165 2005 1147 1152
14. V. Fung, J. Huang, R. Brand, J.P. Newhouse, and J. Hsu Hypertension treatment in a Medicare population: adherence and systolic blood pressure control Clin Ther 29 2007 972 984
15. K.C. Jackson, X. Sheng, R.E. Nelson, A. Keskinaslan, and D.I. Brixner Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database Clin Ther 30 2008 1558 1563
16. M.J. Bloch, and J.N. Basile High adherence to antihypertensive therapy is rare but when present is associated with a decreased risk of cardiovascular events J Clin Hypertens (Greenwich) 12 2010 195 196
17. D.I. Brixner, K.C. Jackson, X. Sheng, R.E. Nelson, and A. Keskinaslan Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free- and fixed-dose combinations Curr Med Res Opin 24 2008 2597 2607
18. G. Hess, J. Hill, H. Lau, H. Dastani, and P. Chaudhari Medication utilization patterns and hypertension-related expenditures among patients who were switched from fixed-dose to free-combination antihypertensive therapy P T 33 2008 652 666
19. W. Yang, J. Chang, K.H. Kahler, T. Fellers, J. Orloff, and E.Q. Wu Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives Curr Med Res Opin 26 2010 2065 2076
20. F. Zeng, B.V. Patel, L. Andrews, F. Frech-Tamas, and A.E. Rudolph Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens Curr Med Res Opin 26 2010 2877 2887
21. R.S. Leslie, F. Gwadry-Sridhar, P. Thiebaud, and B.V. Patel Calculating medication compliance, adherence and persistence in administrative pharmacy claims databases Pharmaceutical Program 1 2008 13 19
22. S. Bangalore, G. Kamalakkannan, S. Parkar, and F.H. Messerli Fixed-dose combinations improve medication compliance: a meta-analysis Am J Med 120 2007 713 719
23. A.K. Gupta, S. Arshad, and N.R. Poulter Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis Hypertension 55 2010 399 407
24. A. Dragomir, R. Cote, L. Roy, L. Blais, L. Lalonde, and A. Berard Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs Med Care 48 2010 418 425
25. M. Dickson, and C.A. Plauschinat Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy Am J Cardiovasc Drugs 8 2008 45 50
26. M.C. Sokol, K.A. McGuigan, R.R. Verbrugge, and R.S. Epstein Impact of medication adherence on hospitalization risk and healthcare cost Med Care 43 2005 521 530
27. G. Mazzaglia, E. Ambrosioni, M. Alacqua, A. Filippi, E. Sessa, and V. Immordino Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients Circulation 120 2009 1598 1605
28. J.E. Bailey, J.Y. Wan, J. Tang, M.A. Ghani, and W.C. Cushman Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death J Gen Intern Med 25 2010 495 503
29. D.G. Pittman, Z. Tao, W. Chen, and G.D. Stettin Antihypertensive medication adherence and subsequent healthcare utilization and costs Am J Manag Care 16 2010 568 576
30. R.J. Butler, T.K. Davis, W.G. Johnson, and H.H. Gardner Effects of nonadherence with prescription drugs among older adults Am J Manag Care 17 2011 153 160
31. W. Yang, K.H. Kahler, T. Fellers, J. Orloff, J. Chang, and A.G. Bensimon Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy J Med Econ 14 2011 267 278
32. C.M. Dezii A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension Manage Care 9 2000 2 6
33. Panjabi SS, Swindle J, Buzinec P, Ramaswamy K, Wacha L. Adherence and medical cost patterns of treatment with RAS inhibitor/amlodipine combinations [abstract]. Presented at: Annual Meeting & Expo of the Academy of Managed Care Pharmacy; San Francisco, CA; April 18-20, 2012.